2 results
Approved WMOCompleted
In this study we will therefore investigate the influence of hypoxia and anti oxidants on HVR and HPV.
Approved WMORecruiting
Dose escalationPrimary• To determine the RP2D of single-agent petosemtamab in mCRC patients who have progressed on chemotherapy, with or without an anti-VEGF therapy, and with an anti-EGFR therapy (if RASwt)Secondary• To characterize the safety and…